Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04450264 · ClinicalTrials.gov registry record · NA

Increasing African Immigrant Women's Participation in Breast Cancer Screening

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
155
Enrollment target

NCT04450264 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 155 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04450264, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
155 participants
Enrollment target

Study Summary

New York City (NYC) is home to a large and diverse immigrant population. Many of these groups face significant barriers to preventive health care, including lack of insurance, poor health care access and language difficulties. Most African immigrant women are likely to live below the poverty line and have low health literacy, are less likely to have health insurance and visit a doctor, particularly for primary/preventive care. Without access to primary care, many preventive services, such as breast cancer screenings go unattended. The barriers and facilitators to breast cancer screening for other minority groups from underserved populations, such as African Americans and Latina women have been studied. Less is known about these for African immigrant women and how to most effectively engage their participation in regular screening. Data of over 2,000 African-born immigrants living in NYC show that 77% report not having health insurance; 75% do not have a primary care physician; and 57% have less than a high school education. As for cancer screening, when corrected for age, 44% have never had a mammogram. Through the study team's unique collaboration with the African Services Committee and the African Advisory Council of the Bronx, two non-governmental community-based service organizations, the study team is poised to have a significant impact on these immigrant women, who have emigrated from more than 20 countries in Africa. This is a population with great need for increased breast cancer knowledge, access to breast cancer screening, and basic medical care. The Health Belief Model (HBM) provides a framework for addressing cultural health barriers by positing that making a decision to engage in a health behavior is determined by weighing perceived threats versus benefits. The long term goal of the proposed project is to conduct a randomized clinical trial that tests the adapted intervention to increase breast cancer screening rates for African-born immigrants. In the

Interventions

  • BEHAVIORAL African Immigrant Breast Cancer Education Program

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2020-02-05
Est. Completion 2023-06-29
Phase NA

What the Registry Record Tells You About NCT04450264

The ClinicalTrials.gov registry entry for NCT04450264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which African Immigrant Breast Cancer Education Program is the first listed.

NCT04450264 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04450264 about?

NCT04450264 is a clinical study titled "Increasing African Immigrant Women's Participation in Breast Cancer Screening". New York City (NYC) is home to a large and diverse immigrant population. Many of these groups face significant barriers to preventive health care, including lack of insurance, poor health care access and language difficulties. Most African immigrant women are likely to live below the poverty line an...

What is the current status of trial NCT04450264?

This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2020-02-05. Estimated completion is 2023-06-29.

What interventions are being tested in trial NCT04450264?

The interventions under investigation include: African Immigrant Breast Cancer Education Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04450264?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.